Does RABEPRAZOLE Cause Second primary malignancy? 13 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Second primary malignancy have been filed in association with RABEPRAZOLE (Rabeprazole Sodium). This represents 0.1% of all adverse event reports for RABEPRAZOLE.
13
Reports of Second primary malignancy with RABEPRAZOLE
0.1%
of all RABEPRAZOLE reports
4
Deaths
9
Hospitalizations
How Dangerous Is Second primary malignancy From RABEPRAZOLE?
Of the 13 reports, 4 (30.8%) resulted in death, 9 (69.2%) required hospitalization, and 2 (15.4%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RABEPRAZOLE. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does RABEPRAZOLE Cause?
Chronic kidney disease (4,773)
Renal failure (3,135)
Acute kidney injury (2,545)
End stage renal disease (1,295)
Tubulointerstitial nephritis (1,125)
Death (857)
Drug ineffective (732)
Dyspnoea (423)
Gastrooesophageal reflux disease (416)
Headache (387)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which RABEPRAZOLE Alternatives Have Lower Second primary malignancy Risk?
RABEPRAZOLE vs RACECADOTRIL
RABEPRAZOLE vs RADIATION THERAPY
RABEPRAZOLE vs RADIUM RA-223 DICHLORIDE
RABEPRAZOLE vs RALOXIFENE
RABEPRAZOLE vs RALTEGRAVIR